|
ATP6V1C1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.89860000000741E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.597700E-02 |
| Normal-vs-Stage2 |
1.112950E-01 |
| Normal-vs-Stage3 |
4.77860000003272E-06 |
| Normal-vs-Stage4 |
1.98896999999976E-05 |
| Stage1-vs-Stage2 |
7.727400E-01 |
| Stage1-vs-Stage3 |
2.806000E-02 |
| Stage1-vs-Stage4 |
1.549760E-02 |
| Stage2-vs-Stage3 |
2.010600E-01 |
| Stage2-vs-Stage4 |
1.280980E-01 |
| Stage3-vs-Stage4 |
6.282600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.9298000000303E-07 |
| Normal-vs-AfricanAmerican |
6.321200E-01 |
| Normal-vs-Asian |
9.982800E-01 |
| Caucasian-vs-AfricanAmerican |
4.786400E-01 |
| Caucasian-vs-Asian |
3.149800E-01 |
| AfricanAmerican-vs-Asian |
8.589200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.10660003172347E-09 |
| Normal-vs-Female |
6.518000E-01 |
| Male-vs-Female |
4.409300E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.620400E-02 |
| Normal-vs-Age(41-60Yrs) |
2.307600E-02 |
| Normal-vs-Age(61-80Yrs) |
1.88130999999592E-05 |
| Normal-vs-Age(81-100Yrs) |
2.325600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.455400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.719200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.520800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.453600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.184400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.413000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.681200E-01 |
| Normal-vs-Grade 2 |
1.501580E-02 |
| Normal-vs-Grade 3 |
1.764030E-04 |
| Normal-vs-Grade 4 |
7.40019999723174E-08 |
| Grade 1-vs-Grade 2 |
2.523000E-01 |
| Grade 1-vs-Grade 3 |
1.844020E-01 |
| Grade 1-vs-Grade 4 |
1.133170E-01 |
| Grade 2-vs-Grade 3 |
1.212170E-01 |
| Grade 2-vs-Grade 4 |
6.951600E-04 |
| Grade 3-vs-Grade 4 |
5.898500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.506000E-01 |
| Normal-vs-ccB subtype |
1.244740E-03 |
| ccA subtype-vs-ccB subtype |
3.142200E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.575900E-03 |
| Normal-vs-N1 |
1.197600E-01 |
| N0-vs-N1 |
5.664400E-01 |
|
|
